Kalaris Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLRS and other ETFs, options, and stocks.About KLRS
Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases.
KLRS Key Statistics
Stock Snapshot
The current Kalaris Therapeutics(KLRS) stock price is $3.90, with a market capitalization of 93.32M. The stock trades at a price-to-earnings (P/E) ratio of -1.94.
During the trading session on 2026-09-05, Kalaris Therapeutics(KLRS) shares reached a daily high of $3.95 and a low of $3.82. At a current price of $3.90, the stock is +2.1% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 23.86K, compared to an average daily volume of 42.64K.
Over the past 52 weeks, Kalaris Therapeutics(KLRS) stock has traded between a high of $11.88 and a low of $3.03.
Over the past 52 weeks, Kalaris Therapeutics(KLRS) stock has traded between a high of $11.88 and a low of $3.03.
KLRS News
...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.